Ardsley Advisory Partners’s Nektar Therapeutics NKTR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-667	Closed	-$235K	–	143
2017 Q1	$235K	Buy	+667	New	+$235K	0.04%	105